Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Sponsor: Mackay Memorial Hospital
Summary
To investigates the effects of botulinum toxin type A bladder injection compared to combined pharmacotherapy with Mirabegron and Solifenacin.
Official title: Evaluation of the Efficacy and Urodynamic Outcomes Between Intradetrusor onabotulinumtoxinA Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Key Details
Gender
FEMALE
Age Range
20 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2021-10-01
Completion Date
2026-12-31
Last Updated
2025-05-09
Healthy Volunteers
No
Interventions
Intradetrusor Botox® (onabotulinumtoxinA) injection
The toxin produced by Clostridium botulinum binds to the nerves endings and inhibits the muscular contractions, help to treat overactivity of the bladder muscles.
Combine Mirabegron and Solifenacin.
Combination pharmacotherapy
Locations (1)
Mackay Memorial Hospital
Taipei, Taiwan